The United States Pharmacopeial Convention (USP), a non-profit, standards setting organisation that advances public health through public standards, has named Kiran Mazumdar-Shaw, CMD of Biocon, on its board of trustees.
Shaw, the second non-US member to join the board of trustees, will help guide USP’s policies, finances and strategic direction. In addition, she will serve as a member of the USP Biologics Advisory Group.
USP develops standards for the identity, purity, quality and strength of medicines, medicinal ingredients, botanical medicinal ingredients, dietary supplements, food ingredients and compounded medicines manufactured, prepared, distributed and consumed worldwide.
Headquartered in the US, it operates facilities with laboratories and customer support operations in Brazil, India and China, with a sales office in Switzerland.